View in EDS HTML Full Text PDF Full Text

Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa.

Saved in:
Bibliographic Details
Title: Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa.
Authors: Pumpalova YS; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA., Ayeni OA; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; SAMRC/Wits Developmental Pathways To Health Research Unit, Department of Pediatrics, Faculty of the Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South Africa Medical Research Council Common Epithelial Cancers Research Centre, University of Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa., Chen WC; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.; Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., O'Neil DS; Sylvester Comprehensive Cancer Center and Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA., Nietz S; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Phakathi B; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Buccimazza I; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; Department of Specialized Surgery, Inkosi Albert Luthuli Central Hospital, University of KwaZulu-Natal, Durban, South Africa., Čačala S; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; Departments of Surgery and Radiation Oncology, Grey's Hospital, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa., Stopforth LW; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; Departments of Surgery and Radiation Oncology, Grey's Hospital, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa., Farrow HA; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; Departments of Surgery and Radiation Oncology, Grey's Hospital, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa., Joffe M; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; SAMRC/Wits Developmental Pathways To Health Research Unit, Department of Pediatrics, Faculty of the Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South Africa Medical Research Council Common Epithelial Cancers Research Centre, University of Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa., Mapanga W; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; Division of Medical Oncology, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Jacobson JS; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA., Crew KD; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA., Cubasch H; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; South Africa Medical Research Council Common Epithelial Cancers Research Centre, University of Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa.; Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Ruff P; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.; South Africa Medical Research Council Common Epithelial Cancers Research Centre, University of Witwatersrand Faculty of Health Sciences, Johannesburg, South Africa.; Division of Medical Oncology, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Neugut AI; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. ain1@columbia.edu.; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. ain1@columbia.edu.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. ain1@columbia.edu.; Division of Medical Oncology, Columbia University Irving Medical Center, 722 West 168th Street, Room 725, New York, NY, 10032, USA. ain1@columbia.edu.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Aug; Vol. 189 (1), pp. 285-296. Date of Electronic Publication: 2021 Jun 14.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-7217
DOI:10.1007/s10549-021-06265-w